title: Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea.
authors.forename: T
authors.initials: T
authors.lastname: Klupa
authors.forename: J
authors.initials: J
authors.lastname: Skupien
authors.forename: B
authors.initials: B
authors.lastname: Mirkiewicz-Sieradzka
authors.forename: A
authors.initials: A
authors.lastname: Gach
authors.forename: A
authors.initials: A
authors.lastname: Noczynska
authors.forename: M
authors.initials: M
authors.lastname: Szalecki
authors.forename: E
authors.initials: E
authors.lastname: Kozek
authors.forename: J
authors.initials: J
authors.lastname: Sieradzki
authors.forename: W
authors.initials: W
authors.lastname: Mlynarski
authors.forename: M T
authors.initials: MT
authors.lastname: Malecki
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000235:genetics*; D003930:Diabetic Retinopathy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult; D000099161:Kcnj11 Channel
chemical_list: D007328:Insulin; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D000099161:Kcnj11 Channel